XML 33 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Leidos stockholders' equity
Leidos stockholders' equity
Cumulative Effect, Period of Adoption, Adjustment
Leidos stockholders' equity
Cumulative Effect, Period of Adoption, Adjusted Balance
Shares of common stock
Shares of common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-controlling interest
Non-controlling interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Jan. 03, 2020             141,000,000 141,000,000                  
Beginning balance at Jan. 03, 2020 $ 3,417 $ (1) $ 3,416 $ 3,413 $ (1) $ 3,412     $ 2,587 $ 2,587 $ 896 $ (1) $ 895 $ (70) $ (70) $ 4 $ 4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income 629     628             628         1  
Other comprehensive income (loss), net of taxes 24     24                   24      
Issuances of stock (in shares)             1,000,000                    
Issuances of stock 36     36         36                
Repurchases of stock and other (105)     (105)         (105)                
Dividends (195)     (195)             (195)            
Stock-based compensation 62     62         62                
Net capital contributions from non-controlling interest 4                             4  
Ending balance (in shares) at Jan. 01, 2021             142,000,000                    
Ending balance at Jan. 01, 2021 3,871     3,862         2,580   1,328     (46)   9  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income 759     753             753         6  
Other comprehensive income (loss), net of taxes 34     34                   34      
Issuances of stock (in shares)             1,000,000                    
Issuances of stock 46     46         46                
Repurchases of stock and other (in shares)             (3,000,000)                    
Repurchases of stock and other (270)     (270)         (270)                
Dividends (201)     (201)             (201)            
Stock-based compensation 67     67         67                
Net capital contributions from non-controlling interest $ 38                             38  
Ending balance (in shares) at Dec. 31, 2021 140,000,000           140,000,000                    
Ending balance at Dec. 31, 2021 $ 4,344     4,291         2,423   1,880     (12)   53  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Net income 693     685             685         8  
Other comprehensive income (loss), net of taxes (61)     (61)                   (61)      
Issuances of stock (in shares)             1,000,000                    
Issuances of stock 51     51         51                
Repurchases of stock and other (in shares)             (4,000,000)                    
Repurchases of stock and other (542)     (542)         (542)                
Dividends (198)     (198)             (198)            
Stock-based compensation 73     73         73                
Net capital distributions to non-controlling interest $ (7)                             (7)  
Ending balance (in shares) at Dec. 30, 2022 137,000,000           137,000,000                    
Ending balance at Dec. 30, 2022 $ 4,353     $ 4,299         $ 2,005   $ 2,367     $ (73)   $ 54